Healthcare & Life Sciences Industry Updates

Google News – EMA (biotech/pharma) External News

At request of AstraZeneca, Europe withdraws marketing authorization of COVID vaccine Vaxzevria - Fierce Pharma

news.google.com · 10 Jul 2026

Google News – EMA (biotech/pharma) External News

AOB Pharma receives European Medicines Agency (EMA) positive decision on the pediatric investigation plan (PIP), supporting future development of B244 for the treatment of mild to moderate atopic dermatitis in children, adolescents, and adults in the Europ - PR Newswire

news.google.com · 10 Jul 2026

Google News – EMA (biotech/pharma) External News

FDA and EMA release collaborative AI framework for drug development - Clinical Trials Arena

news.google.com · 10 Jul 2026

Google News – EMA (biotech/pharma) External News

LEO Pharma Submits Adolescent Label Expansion Application for Anzupgo® to EMA - BioSpace

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

Pharmalittle: We're reading about FDA reforming clinical trials, a Pfizer setback, and much more news - STAT

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA approves Denali's Hunter syndrome drug, handing rare disease community a win - Fierce Pharma

news.google.com · 10 Jul 2026

Google News – Medical Devices External News

CMS and FDA Announce New RAPID Program for Medicare Coverage of Breakthrough Medical Devices - Latham & Watkins LLP

news.google.com · 10 Jul 2026

Google News – Medical Devices External News

The UK's MHRA Opens Public Consultation on Indefinite CE Mark Recognition of Medical Devices and IVDs - Jones Day

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Fate Therapeutics Announces FDA Clearance of IND for FT839 Dual-CAR T Cell Therapy in Autoimmune Disease - Quiver Quantitative

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Quoin Pharmaceuticals Announces FDA Clearance of QRX003 IND for Peeling Skin Syndrome, Plans Phase 2 Study in 2H 2026 - Quiver Quantitative

news.google.com · 10 Jul 2026

Google_site External News

HSA Alert: Three Products Found to Contain Potent Medicinal Ingredients including High Levels of Banned Substance Sibutramine and Erectile Dysfunction Medicines - Health Sciences Authority

news.google.com · 10 Jul 2026

Industry News External News

Editorial | Independent drug approvals are key to Hong Kong’s biotech ambitions - South China Morning Post

news.google.com · 10 Jul 2026

Google News – EMA (biotech/pharma) External News

EMA fast-tracks review of Revolutions' experimental pancreatic cancer pill - ET Pharma

news.google.com · 10 Jul 2026

Google News – EMA (biotech/pharma) External News

Latest new meds recommended for approval by EMA’s CHMP - The Pharma Letter

news.google.com · 10 Jul 2026

Google News – EMA (biotech/pharma) External News

Teva to acquire Emalex Biosciences - The Pharma Letter

news.google.com · 10 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

At request of AstraZeneca, Europe withdraws marketing authorization of COVID vaccine Vaxzevria - Fierce Pharma

AOB Pharma receives European Medicines Agency (EMA) positive decision on the pediatric investigation plan (PIP), supporting future development of B244 for the treatment of mild to moderate atopic dermatitis in children, adolescents, and adults in the Europ - PR Newswire

FDA and EMA release collaborative AI framework for drug development - Clinical Trials Arena

LEO Pharma Submits Adolescent Label Expansion Application for Anzupgo® to EMA - BioSpace

Pharmalittle: We're reading about FDA reforming clinical trials, a Pfizer setback, and much more news - STAT

FDA approves Denali's Hunter syndrome drug, handing rare disease community a win - Fierce Pharma

CMS and FDA Announce New RAPID Program for Medicare Coverage of Breakthrough Medical Devices - Latham & Watkins LLP

The UK's MHRA Opens Public Consultation on Indefinite CE Mark Recognition of Medical Devices and IVDs - Jones Day

Fate Therapeutics Announces FDA Clearance of IND for FT839 Dual-CAR T Cell Therapy in Autoimmune Disease - Quiver Quantitative

Quoin Pharmaceuticals Announces FDA Clearance of QRX003 IND for Peeling Skin Syndrome, Plans Phase 2 Study in 2H 2026 - Quiver Quantitative

HSA Alert: Three Products Found to Contain Potent Medicinal Ingredients including High Levels of Banned Substance Sibutramine and Erectile Dysfunction Medicines - Health Sciences Authority

Editorial | Independent drug approvals are key to Hong Kong’s biotech ambitions - South China Morning Post

EMA fast-tracks review of Revolutions' experimental pancreatic cancer pill - ET Pharma

Latest new meds recommended for approval by EMA’s CHMP - The Pharma Letter

Teva to acquire Emalex Biosciences - The Pharma Letter